Santhera Pharmaceuticals Holding AG (XSWX:SANN) Inventory Turnover: 1.17 (As of Dec. 2025)

What is Santhera Pharmaceuticals Holding AG Inventory Turnover?

Santhera Pharmaceuticals Holding AG XSWX:SANN -0.26% 39 Inventory Turnover is 1.17 as of Dec. 2025. GuruFocus rates XSWX:SANN with a GF Score™ of 39/100 and a GF Value™ of CHF23.24 (Possible Value Trap). The stock has 6 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Santhera Pharmaceuticals Holding AG's Cost of Goods Sold for the six months ended in Dec. 2025 was CHF29.89 Mil. Santhera Pharmaceuticals Holding AG's Average Total Inventories for the quarter that ended in Dec. 2025 was CHF25.45 Mil. Santhera Pharmaceuticals Holding AG's Inventory Turnover for the quarter that ended in Dec. 2025 was 1.17.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Santhera Pharmaceuticals Holding AG's Days Inventory for the six months ended in Dec. 2025 was 155.39.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Santhera Pharmaceuticals Holding AG's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.48.

Santhera Pharmaceuticals Holding AG (XSWX:SANN) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Santhera Pharmaceuticals Holding AG's Days Inventory for the six months ended in Dec. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2025 )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
	=	25.449	/	29.888	*	365 / 2
	=	155.39

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Santhera Pharmaceuticals Holding AG's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	25.449	/	53.172
	=	0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Santhera Pharmaceuticals Holding AG Inventory Turnover Related Terms

Santhera Pharmaceuticals Holding AG Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Santhera Pharmaceuticals Holding AG's Inventory Turnover can be seen below:

Santhera Pharmaceuticals Holding AG Inventory Turnover Chart

Santhera Pharmaceuticals Holding AG Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

8.29

13.40

3.37

1.61

2.93

Santhera Pharmaceuticals Holding AG Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Inventory Turnover	Get a 7-Day Free Trial															0.72	1.33	0.88	1.47	1.17

39GF Score

Santhera Pharmaceuticals Holding AG XSWX:SANN

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Santhera Pharmaceuticals Holding AG Inventory Turnover Calculation

Santhera Pharmaceuticals Holding AG's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	62.011	/ (	(17.527	+	24.868)	/	2 )
=	62.011	/	21.1975
=	2.93

Santhera Pharmaceuticals Holding AG's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

	Inventory Turnover (Q: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Dec. 2025 )	/ (	(Total Inventories (Q: Jun. 2025 )	+	Total Inventories (Q: Dec. 2025 ))	/	count )
=	29.888	/ (	(26.03	+	24.868)	/	2 )
=	29.888	/	25.449
=	1.17

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 1.17 mean?

Santhera Pharmaceuticals Holding AG (XSWX:SANN) has a Inventory Turnover of 1.17 as of Dec. 2025. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Santhera Pharmaceuticals Holding AG and its competitors.

Is Santhera Pharmaceuticals Holding AG's Inventory Turnover too high?

Santhera Pharmaceuticals Holding AG's current Inventory Turnover is 1.17. Overall, Santhera Pharmaceuticals Holding AG has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Santhera Pharmaceuticals Holding AG's Inventory Turnover compare to VRTX and REGN?

Santhera Pharmaceuticals Holding AG's Inventory Turnover of 1.17 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Biotechnology company?

A good Inventory Turnover depends on the Biotechnology industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Santhera Pharmaceuticals Holding AG and its competitors. Santhera Pharmaceuticals Holding AG's current Inventory Turnover is 1.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Santhera Pharmaceuticals Holding AG stock overvalued right now?

Based on GuruFocus' analysis, Santhera Pharmaceuticals Holding AG (XSWX:SANN) is currently considered Possible Value Trap. The stock's GF Value™ is CHF23.24, compared to a current price of CHF15.20 — trading 34.6% below its estimated fair value. The current Inventory Turnover is 1.17. Santhera Pharmaceuticals Holding AG's overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Santhera Pharmaceuticals Holding AG (XSWX:SANN), the current Inventory Turnover is 1.17 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Santhera Pharmaceuticals Holding AG (XSWX:SANN) Overvalued in 2026?

Based on GuruFocus' analysis, Santhera Pharmaceuticals Holding AG stock appears to be undervalued. The current stock price of CHF15.20 is trading 34.6% below its estimated GF Value™ of CHF23.24. GuruFocus considers Santhera Pharmaceuticals Holding AG to be Possible Value Trap.

Key valuation signals for XSWX:SANN:

Inventory Turnover: 1.17
GF Value™: CHF23.24 vs. price of CHF15.20 (34.6% below fair value)
GF Score™: 39/100 with 6 warning signs

No single metric tells the full story. See the XSWX:SANN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Santhera Pharmaceuticals Holding AG Business Description

Industry Healthcare Biotechnology

Comparable Companies XSWX:NWRN XSWX:BIOV XSWX:MOLN XSWX:XLS XSWX:MMTX XSWX:ADXN XSWX:BSLN VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA XKRX:068270 RPRX ROIV

Other Exchanges SPHDF:USA SANNz:UK 0QN1:UK S3F0:Germany

Address Hohenrainstrasse 24, Pratteln, CHE, 4133

Website https://www.santhera.com

Santhera Pharmaceuticals Holding AG is a Swiss specialty pharmaceutical company committed to developing and commercializing medicines to meet the needs of patients living with rare and other diseases with high unmet medical needs. It is focused on the development of treatments for pulmonary and neuromuscular diseases that currently lack treatment options. The company is currently engaged in the rollout of its AGAMREE (vamorolone) medicine for the treatment of Duchenne muscular dystrophy (DMD) globally. Santhera has one operating segment, namely the development and commercialization of products for the treatment of neuromuscular diseases. Geographically, the company generates maximum revenue from Europe, and the rest from Asia and North America.

39GF Score

Get the complete analysis for XSWX:SANN

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF15.20

Price

CHF23.24

GF Value

View XSWX:SANN Analysis

See Inventory Turnover data for all stocks →